XETRA - Delayed Quote • EUR
MeVis Medical Solutions AG (M3V.DE)
At close: 5:36 PM GMT+2
Breakdown
TTM
9/30/2023
9/30/2022
9/30/2021
9/30/2020
Total Revenue
17,342.00
17,342.00
18,762.00
16,214.00
17,131.00
Cost of Revenue
445.25
445.25
746.56
436.85
626.21
Gross Profit
16,896.75
16,896.75
18,015.44
15,777.15
16,504.79
Operating Expense
11,991.79
11,991.79
11,545.14
10,750.09
10,334.04
Operating Income
4,904.96
4,904.96
6,470.29
5,027.06
6,170.75
Net Non Operating Interest Income Expense
67.82
67.82
-3.85
150.97
162.93
Pretax Income
5,033.78
5,033.78
7,876.63
4,630.68
5,794.45
Tax Provision
114.18
114.18
87.11
85.00
90.48
Net Income Common Stockholders
4,919.55
4,919.55
7,789.05
4,545.68
5,703.91
Diluted NI Available to Com Stockholders
4,919.55
4,919.55
7,789.05
4,545.68
5,703.91
Basic EPS
2.70
--
4.28
2.50
3.13
Diluted EPS
2.70
--
4.28
2.50
3.13
Basic Average Shares
1,820.00
--
1,820.00
1,820.00
1,820.00
Diluted Average Shares
1,820.00
--
1,820.00
1,820.00
1,820.00
Rent Expense Supplemental
518.00
518.00
552.00
461.00
431.00
Total Expenses
12,437.04
12,437.04
12,291.71
11,186.94
10,960.25
Net Income from Continuing & Discontinued Operation
4,919.55
4,919.55
7,789.05
4,545.68
5,703.91
Normalized Income
4,919.55
4,919.55
7,789.05
5,142.52
5,999.22
Interest Income
110.64
110.64
--
161.79
174.65
Interest Expense
42.82
42.82
3.85
10.82
11.73
Net Interest Income
67.82
67.82
-3.85
150.97
162.93
EBIT
5,076.60
5,076.60
7,880.48
4,641.50
5,806.18
EBITDA
5,172.44
5,172.44
7,973.53
4,767.02
5,973.69
Reconciled Cost of Revenue
445.25
445.25
746.56
436.85
626.21
Reconciled Depreciation
95.84
95.84
93.05
125.51
167.51
Net Income from Continuing Operation Net Minority Interest
4,919.55
4,919.55
7,789.05
4,545.68
5,703.91
Total Unusual Items Excluding Goodwill
--
--
--
-608.00
-300.00
Total Unusual Items
--
--
--
-608.00
-300.00
Normalized EBITDA
5,172.44
5,172.44
7,973.53
5,375.02
6,273.69
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
--
--
--
-11.16
-4.68
9/30/2020 - 11/16/2007
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade